Innovating to improve health worldwide
We are the voice of the innovative pharmaceutical industry, collaborating for global health progress to improve lives everywhere.
Call for special pathogen sharing measures to be included in COP15 Digital Sequence Information negotiations
IFPMA statement on behalf of the pharmaceutical industry at the Convention on Biological Diversity (CBD) COP 15 meeting regarding Digital Sequence Information.
Improving child health around the world through immunisation
Ever since the smallpox vaccine discovery over two centuries ago, vaccines have successfully worked to eradicate, eliminate, or control many infectious diseases.
Life-course immunization: Benchmarking main markets and model countries
Immunization is the greatest success story of the twentieth century. Vaccines eliminated most of the childhood diseases that used to cause millions of deaths, making possible a life without disabilities caused by certain communicable diseases like polio for the first time in human history.
IFPMA announces Sunao Manabe as new Vice President
Today, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced Sunao Manabe, President and Chief Executive Officer (CEO) at Daiichi Sankyo, as IFPMA Vice President. IFPMA President and CEO of UCB, Jean-Christophe Tellier welcomes Sunao Manabe, President and CEO of Daiichi Sankyo to IFPMA leadership team. “I am thrilled Sunao will join IFPMA’s leadership team,”...
Collaborating for global health progress
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents the innovative pharmaceutical industry at the international level and in official relations with the United Nations.About us
Areas of workSee all
Representing over 90 of the most forward-looking companies and associations in the world.